Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2011

01.07.2011 | Colorectal Cancer

Association of C-reactive Protein Gene Polymorphisms and Colorectal Cancer

verfasst von: Shung-Haur Yang, MD, PhD, Chi-Jung Huang, PhD, Shih-Ching Chang, MD, PhD, Jen-Kou Lin, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

An elevated plasma level of C-reactive protein (CRP) is a risk for, and prognostic factor of, colorectal cancer (CRC). In other reports of CRP concerning cardiovascular disease, CRP level correlated with its gene polymorphisms. We hypothesized that CRP polymorphisms associate risk and prognosis of CRC.

Methods

This study enrolled 421 patients with CRC and 218 healthy control subjects. After preliminary studies, we selected four single nucleotide polymorphisms (SNPs) in the CRP gene: +2147A > G (rs1205), +942G > C (rs1800947), −717A > G (rs2794521), and −757T > C (rs3093059). At first, analyzing distributions of four SNPs between CRC case and non-CRC control groups was performed. Subsequently, the impacts of these SNPs with other prognostic factors of disease-free interval (DFI) and cancer-specific survival (CSS) were analyzed using uni- and multivariate Cox regression analyses.

Results

The case and control groups differed in the frequency of −757T > C (P = 0.002). The CRC case group had a higher percentage of the TT genotype (odds, 1.75). Regarding prognoses, multivariate analyses revealed that four factors, including stage (I, II, III), gross tumor type (polypoid, ulcerative, infiltrative), location (right, left, rectum), and −757T > C SNP (odds, 1.29; P = 0.048), correlated with DFI; two factors, including stage and +2147A > G SNP (odds, 0.71; P = 0.03), correlated with CSS.

Conclusions

The −757T > C SNP is a risk for and prognostic factor of DFI; the +2147A > G SNP is a prognostic factor of CSS. CRP polymorphisms associate the risk and survival of CRC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer [see comment]. JAMA. 2004;291(5):585–90.PubMedCrossRef Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer [see comment]. JAMA. 2004;291(5):585–90.PubMedCrossRef
2.
Zurück zum Zitat Shiu YM, Lin JK, Huang CJ, et al. Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum. 2008;51(4):443–9.PubMedCrossRef Shiu YM, Lin JK, Huang CJ, et al. Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum. 2008;51(4):443–9.PubMedCrossRef
3.
Zurück zum Zitat Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2063–9.PubMedCrossRef Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2063–9.PubMedCrossRef
4.
Zurück zum Zitat Szalai AJ, Wu J, Lange EM, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med. 2005;83(6):440–7.PubMedCrossRef Szalai AJ, Wu J, Lange EM, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med. 2005;83(6):440–7.PubMedCrossRef
5.
Zurück zum Zitat Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162(1):217–9.PubMedCrossRef Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162(1):217–9.PubMedCrossRef
6.
Zurück zum Zitat Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359(18):1897–908.PubMedCrossRef Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359(18):1897–908.PubMedCrossRef
7.
Zurück zum Zitat Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66(4):2483–7.PubMedCrossRef Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66(4):2483–7.PubMedCrossRef
8.
Zurück zum Zitat Sansbury LB, Bergen AW, Wanke KL, et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev. 2006;15(3):494–501.PubMedCrossRef Sansbury LB, Bergen AW, Wanke KL, et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev. 2006;15(3):494–501.PubMedCrossRef
9.
Zurück zum Zitat Heikkila K, Silander K, Salomaa V, et al. C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. Eur J Cancer. (2010). doi:10.1016/j.ejca.2010.07.032. Heikkila K, Silander K, Salomaa V, et al. C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. Eur J Cancer. (2010). doi:10.​1016/​j.​ejca.​2010.​07.​032.
10.
Zurück zum Zitat Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24(33):5216–22.PubMedCrossRef Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24(33):5216–22.PubMedCrossRef
11.
Zurück zum Zitat Poole EM, Bigler J, Whitton J, et al. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genom. 2009;19(2):113–20.CrossRef Poole EM, Bigler J, Whitton J, et al. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genom. 2009;19(2):113–20.CrossRef
12.
Zurück zum Zitat Tsilidis KK, Helzlsouer KJ, Smith MW, et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control. 2009;20(9):1739–51.PubMedCrossRef Tsilidis KK, Helzlsouer KJ, Smith MW, et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control. 2009;20(9):1739–51.PubMedCrossRef
13.
Zurück zum Zitat Greene FL PD, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual, 6th edn. Chicago: Springer; 2002.CrossRef Greene FL PD, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual, 6th edn. Chicago: Springer; 2002.CrossRef
14.
Zurück zum Zitat Wang LW, Yang SH, Lin JK, et al. Preoperative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol. 2005;89(4):256–63; discussion 263–4.PubMedCrossRef Wang LW, Yang SH, Lin JK, et al. Preoperative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol. 2005;89(4):256–63; discussion 263–4.PubMedCrossRef
15.
Zurück zum Zitat Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229–37.PubMedCrossRef Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229–37.PubMedCrossRef
16.
Zurück zum Zitat Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.PubMedCrossRef Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.PubMedCrossRef
17.
Zurück zum Zitat Ben Assayag E, Shenhar-Tsarfaty S, Bova I, et al. Association of the −757T > C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res. 2009;124(4):458–62.PubMedCrossRef Ben Assayag E, Shenhar-Tsarfaty S, Bova I, et al. Association of the −757T > C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res. 2009;124(4):458–62.PubMedCrossRef
18.
Zurück zum Zitat Teng MS, Hsu LA, Wu S, et al. Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: interaction with obesity. Atherosclerosis. 2009;204(2):e64–9.PubMedCrossRef Teng MS, Hsu LA, Wu S, et al. Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: interaction with obesity. Atherosclerosis. 2009;204(2):e64–9.PubMedCrossRef
19.
Zurück zum Zitat Wang L, Lu X, Li Y, et al. Functional analysis of the C-reactive protein (CRP) gene -717A > G polymorphism associated with coronary heart disease. BMC Med Genet. 2009;10:73.PubMedCrossRef Wang L, Lu X, Li Y, et al. Functional analysis of the C-reactive protein (CRP) gene -717A > G polymorphism associated with coronary heart disease. BMC Med Genet. 2009;10:73.PubMedCrossRef
20.
Zurück zum Zitat Elliott P, Chambers JC, Zhang W, et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302(1):37–48.PubMedCrossRef Elliott P, Chambers JC, Zhang W, et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302(1):37–48.PubMedCrossRef
21.
Zurück zum Zitat Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13):2217–24.PubMedCrossRef Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13):2217–24.PubMedCrossRef
22.
Zurück zum Zitat Zhang SM, Buring JE, Lee IM, et al. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med. 2005;142(6):425–32.PubMed Zhang SM, Buring JE, Lee IM, et al. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med. 2005;142(6):425–32.PubMed
23.
Zurück zum Zitat Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007;50(12):1115–22.PubMedCrossRef Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007;50(12):1115–22.PubMedCrossRef
24.
Zurück zum Zitat Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis. 2001;154(3):681–9.PubMedCrossRef Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis. 2001;154(3):681–9.PubMedCrossRef
25.
Zurück zum Zitat Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 2002;53(4):1029–34.PubMedCrossRef Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 2002;53(4):1029–34.PubMedCrossRef
26.
Zurück zum Zitat Wang Q, Hunt SC, Xu Q, et al. Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol. 2006;291(6):H2752–7.PubMedCrossRef Wang Q, Hunt SC, Xu Q, et al. Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol. 2006;291(6):H2752–7.PubMedCrossRef
27.
Zurück zum Zitat Zee RY, Germer S, Thomas A, et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis. 2008;197(2):931–6.PubMedCrossRef Zee RY, Germer S, Thomas A, et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis. 2008;197(2):931–6.PubMedCrossRef
28.
Zurück zum Zitat Hung AM, Crawford DC, Griffin MR, et al. CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol. 2010;5(1):24–33.PubMedCrossRef Hung AM, Crawford DC, Griffin MR, et al. CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol. 2010;5(1):24–33.PubMedCrossRef
29.
Zurück zum Zitat Halder I, Marsland AL, Cheong J, et al. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun. 2010;24(1):160–7.PubMedCrossRef Halder I, Marsland AL, Cheong J, et al. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun. 2010;24(1):160–7.PubMedCrossRef
30.
Zurück zum Zitat Wang Q, Ding H, Tang JR, et al. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin. 2009;30(3):291–8.PubMedCrossRef Wang Q, Ding H, Tang JR, et al. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin. 2009;30(3):291–8.PubMedCrossRef
31.
Zurück zum Zitat Ognjanovic S, Yamamoto J, Saltzman B, et al. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control. 2010;21(7):1131–8.PubMedCrossRef Ognjanovic S, Yamamoto J, Saltzman B, et al. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control. 2010;21(7):1131–8.PubMedCrossRef
32.
Zurück zum Zitat Crawford DC, Sanders CL, Qin X, et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation. 2006;114(23):2458–65.PubMedCrossRef Crawford DC, Sanders CL, Qin X, et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation. 2006;114(23):2458–65.PubMedCrossRef
33.
Zurück zum Zitat Eiriksdottir G, Smith AV, Aspelund T, et al. The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J Obes (Lond). 2009;33(2):267–72.CrossRef Eiriksdottir G, Smith AV, Aspelund T, et al. The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J Obes (Lond). 2009;33(2):267–72.CrossRef
34.
Zurück zum Zitat Kolz M, Koenig W, Muller M, et al. DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. Eur Heart J. 2008;29(10):1250–8.PubMedCrossRef Kolz M, Koenig W, Muller M, et al. DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. Eur Heart J. 2008;29(10):1250–8.PubMedCrossRef
35.
Zurück zum Zitat Schumacher W, Cockcroft J, Timpson NJ, et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension. 2009;53(2):150–7.PubMedCrossRef Schumacher W, Cockcroft J, Timpson NJ, et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension. 2009;53(2):150–7.PubMedCrossRef
36.
Zurück zum Zitat Shen J, Arnett DK, Parnell LD, et al. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care. 2008;31(5):910–5.PubMedCrossRef Shen J, Arnett DK, Parnell LD, et al. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care. 2008;31(5):910–5.PubMedCrossRef
37.
Zurück zum Zitat Su S, Lampert R, Zhao J, et al. Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. Am J Cardiol. 2009;104(12):1748–54.PubMedCrossRef Su S, Lampert R, Zhao J, et al. Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. Am J Cardiol. 2009;104(12):1748–54.PubMedCrossRef
38.
Zurück zum Zitat Sheu WH, Chen YD, Yu CY, et al. C-reactive protein gene polymorphism 1009A > G is associated with serum CRP levels in Chinese men: a TCVGHAGE study. Clin Chim Acta. 2007;382(1-2):117–23.PubMedCrossRef Sheu WH, Chen YD, Yu CY, et al. C-reactive protein gene polymorphism 1009A > G is associated with serum CRP levels in Chinese men: a TCVGHAGE study. Clin Chim Acta. 2007;382(1-2):117–23.PubMedCrossRef
39.
Zurück zum Zitat Chiu HM, Lin JT, Chen TH, et al. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol. 2008;103(9):2317–25.PubMedCrossRef Chiu HM, Lin JT, Chen TH, et al. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol. 2008;103(9):2317–25.PubMedCrossRef
Metadaten
Titel
Association of C-reactive Protein Gene Polymorphisms and Colorectal Cancer
verfasst von
Shung-Haur Yang, MD, PhD
Chi-Jung Huang, PhD
Shih-Ching Chang, MD, PhD
Jen-Kou Lin, MD, PhD
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1575-9

Weitere Artikel der Ausgabe 7/2011

Annals of Surgical Oncology 7/2011 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.